ArticleMolecular cancer research : MCR2022

Molecular Profile Changes in Patients with Castrate-Resistant Prostate Cancer Pre- and Post-Abiraterone/Prednisone Treatment.

Hugues Sicotte et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.